Literature DB >> 16408905

Liphagal, a Selective inhibitor of PI3 kinase alpha isolated from the sponge akacoralliphaga: structure elucidation and biomimetic synthesis.

Frederic Marion1, David E Williams, Brian O Patrick, Irwin Hollander, Robert Mallon, Steven C Kim, Deborah M Roll, Larry Feldberg, Rob Van Soest, Raymond J Andersen.   

Abstract

[structure: see text] Liphagal (1), a selective inhibitor of PI3K alpha, has been isolated from the marine sponge Aka coralliphaga collected in Dominica. The "liphagane" meroterpenoid carbon skeleton of liphagal (1) is new. A biomimetic total synthesis has been used to confirm the constitution of liphagal (1) and support a proposed biogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16408905     DOI: 10.1021/ol052744t

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  24 in total

1.  Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity.

Authors:  Jinan Wang; Fangfang Wang; Zhengtao Xiao; Guowen Sheng; Yan Li; Yonghua Wang
Journal:  J Mol Model       Date:  2011-12-03       Impact factor: 1.810

2.  The catalytic enantioselective total synthesis of (+)-liphagal.

Authors:  Joshua J Day; Ryan M McFadden; Scott C Virgil; Helene Kolding; Jennifer L Alleva; Brian M Stoltz
Journal:  Angew Chem Int Ed Engl       Date:  2011-06-10       Impact factor: 15.336

Review 3.  MAPK signaling pathway-targeted marine compounds in cancer therapy.

Authors:  Jiaen Wei; Ruining Liu; Xiyun Hu; Tingen Liang; Zhiran Zhou; Zunnan Huang
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-03       Impact factor: 4.553

4.  Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases.

Authors:  Dima A Sabbah; Jonathan L Vennerstrom; Haizhen Zhong
Journal:  J Chem Inf Model       Date:  2010-10-25       Impact factor: 4.956

5.  Platinum-Catalyzed α,β-Unsaturated Carbene Formation in the Formal Syntheses of Frondosin B and Liphagal.

Authors:  Khoi Q Huynh; Curtis A Seizert; Tarik J Ozumerzifon; Paul A Allegretti; Eric M Ferreira
Journal:  Org Lett       Date:  2016-12-20       Impact factor: 6.005

Review 6.  The PIK3CA gene as a mutated target for cancer therapy.

Authors:  John P Gustin; David P Cosgrove; Ben Ho Park
Journal:  Curr Cancer Drug Targets       Date:  2008-12       Impact factor: 3.428

7.  Marine natural meroterpenes: synthesis and antiproliferative activity.

Authors:  Annabel Simon-Levert; Christophe Menniti; Laurent Soulère; Anne-Marie Genevière; Chantal Barthomeuf; Bernard Banaigs; Anne Witczak
Journal:  Mar Drugs       Date:  2010-02-23       Impact factor: 5.118

Review 8.  Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds.

Authors:  Alejandro M S Mayer; Kirk R Gustafson
Journal:  Eur J Cancer       Date:  2008-08-11       Impact factor: 9.162

Review 9.  Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia.

Authors:  John E Paes; Matthew D Ringel
Journal:  Endocrinol Metab Clin North Am       Date:  2008-06       Impact factor: 4.741

Review 10.  Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors.

Authors:  Mark E Welker; George Kulik
Journal:  Bioorg Med Chem       Date:  2013-05-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.